绿茶摄入超过四周对动脉粥样硬化标志物的影响
过量摄入绿茶的15种副作用

过量摄入绿茶的15种副作用绿茶是最健康的饮料之一。
它来自山茶花植物。
绿茶含有一种称为EGCG的抗氧化剂,具有抗击多种疾病,例如癌症,心脏病和肥胖症。
但是新的研究表明,每天喝太多绿茶可能有副作用。
绿茶副作用喝太多绿茶有副作用。
要警惕的15种不利健康的影响。
1.绿茶中的EGCG与铁结合,导致贫血和铁缺乏全球有16.2亿人贫血。
它是由于铁缺乏和血液中血红蛋白低引起的。
研究表明,每天喝太多绿茶可能会导致铁缺乏症,从而导致贫血或红细胞计数低。
宾夕法尼亚州立大学助理教授解释说,特定的绿茶素EGCG与铁结合。
降低了作为有效抗氧化剂的EGCG的效率,还阻碍了铁的吸收。
可能导致炎症和胃痛。
2.绿茶中的咖啡因会干扰某些药物咖啡因是一种CNS(中枢神经系统)刺激剂。
在某些药物上食用大量绿茶可能会引起副作用。
咖啡因在体内被分解。
但是,某些药物如西咪替丁,抗生素像环丙沙星,依诺沙星(Penetrex),曲伐沙星(Trovan),司帕沙星(Zagam),诺氟沙星(Chibroxin,Noroxin),格帕沙星(Raxar),氟康唑,麻醉药物像咪达唑仑,和避孕药。
会使咖啡因继续存在于体内,引起躁动,心律加快,在某些情况下还会导致心律不齐。
科学家们发现,绿茶中的咖啡因抑制代谢的氯氮平-抗精神病药物,导致氯氮平中毒。
研究表明,绿茶中的维生素K会抑制华法林(一种抗凝(抗凝血)药物)的作用。
3.怀孕期间喝绿茶可能会导致生育缺陷多项研究表明,怀孕期间喝过量的绿茶可能会对母亲和新生儿产生负面影响。
每天超过300毫克的咖啡因,增加了高血压的怀孕风险。
科学家还发现,绿茶中的咖啡因和丹宁酸可以降低叶酸的含量。
叶酸是一种水溶性的B族维生素,可防止流产和先天性脊柱裂等先天性畸形。
此外,喝过量的绿茶可能会增加早产的风险。
4.绿茶中的咖啡因可能导致低钾血症和癫痫发作低钾血症的特征是血液中钾含量低。
钾对于肌肉收缩和人体蛋白质的功能很重要。
喝太多的绿茶可能会降低钾水平,导致肌肉无力。
男性常喝绿茶的好处和坏处

男性常喝绿茶的好处和坏处绿茶是很多人在日常生活中经常喝的,对于男性朋友来说,经常喝绿茶有一定的好处,不过也有一些坏处是需要了解的。
以下是男性喝绿茶有哪些处和坏处,欢迎阅读!男性喝绿茶的好处绿茶应该天天喝相关研究还表明,亚洲人喝绿茶的习惯也对防治前列腺疾病起到一定作用。
日本近期的研究报告显示,每天喝5杯或以上的绿茶能够把患上前列腺癌的风险减少一半。
研究小组称:绿茶中的儿茶素能够抑制男性睾丸激素的分泌,从而减少患前列腺癌的风险,睾丸激素被认为是前列腺癌的诱因。
报告认为,亚洲男性患前列腺癌的病例比西方男性少,这可能同亚洲人爱喝绿茶有关。
随着喝茶的数量和时间递增,绿茶的作用就表现得越明显。
西方的男性吃饭前后一般会喝酒,容易使前列腺充血。
德国专家建议,可以像亚洲人一样吃饭时喝点茶,即使喝酒也只能喝一些酒精含量较低的红酒。
多吃豆类和蔬菜西方人一直没有吃豆制品的习惯,但是亚洲人喜欢吃的豆制品中确实藏有前列腺癌的克星。
大豆中的异黄酮能降低雄性激素的破坏作用,并抑制和杀死癌细胞。
西方人吃蔬菜量太少,应该像日本人和中国人那样多吃各种蔬菜。
除了中国的白菜外,还有菜花、西蓝花等蔬菜也有防治前列腺癌的功效。
另外,每天还可以吃点亚麻籽、西红柿。
西红柿含有番茄红素,对前列腺癌有防治作用。
专家们结合西方饮食与亚洲饮食,制定了一个防治前列腺疾病的食谱:早餐时,喝一杯西红柿汁;午餐时,吃一碗含有胡萝卜、卷心菜或西蓝花的沙拉或水煮蔬菜;晚餐时,吃一点豆类,或是改吃糙米饭;肚子饿的时候,随时吃点萝卜、西红柿,既不发胖,对防治前列腺癌又有好处。
男性喝绿茶的坏处绿茶的好处虽多,但不是所有的人都适合喝。
绿茶的坏处与绿茶的好处息息相关,同样的作用对普通人也许是好处,而在特定的情况下或者对特定的人群会有一定的负作用。
所谓的不适宜喝,更准确地应该说是避免经常喝,大量喝和喝浓茶。
偶尔品个一两杯,也不失为一种生活情趣,而对健康也不会有太大影响。
另外健康的人喝绿茶也并不是百无禁忌的,如果一些事项不加注意,也会对身体带来危害。
2022其他饮食成分对动脉粥样硬化疾病的影响

2022其他饮食成分对动脉粥样硬化疾病的影响(全文)食物选择是影响健康的最重要因素, 饮食因素占所有心血管疾病死亡人数的近50%。
根据全球疾病负担研究, 全球有超过910万例过早死亡(占所有心血管疾病死亡人数的52%)可归因于饮食相关风险[1]。
其他与生活方式相关的因素(如吸烟和低体力活动)以及个体的遗传背景可以改变心血管风险, 也可以调节饮食对动脉粥样硬化的影响。
盐对人体的血压和心血管系统有双重作用, 高钠饮食可以升高血压, 随之使心血管病危险增加。
既往的临床证据显示, 低钠饮食可以降低血压和预防心血管疾病的发生[2]。
尽管限盐作为作为预防高血压和心血管病的研究已经进行了 1余年, 但是, 理想范围钠的摄入量目前仍在争论中。
饮茶是世界上最普通的不含任何热量的饮料, 我国和亚洲其他国家主要饮绿茶。
早期的流行病学调查和动物实验证实, 饮茶对健康有益[3]。
本文将系统回顾盐、饮料、巧克力和膳食微量营养素补充剂与动脉粥样硬化疾病的相关性。
1 盐盐作为心血管病的潜在危险因素受到了广泛关注。
然而, 关于膳食钠摄入量与心血管病风险之间的剂量反应关联的证据并不总是一致的, 并且在许多荟萃分析中, 纳入研究的异质性很高。
差异的部分原因可能是观察性研究中常见的方法学错误, 包括反向因果关系、钠摄入量评估中的系统性和随机性错误、盐敏感性的个体差异以及残余混杂因素[4]。
最近一项对 24个队列研究的综合荟萃分析表明, 与钠摄入量低的者比较, 钠摄入量高者患心血管疾病的风险更高(HR=1.19 ), 每增加1 g钠摄入量, 心血管疾病的风险增加高达6%[5]。
这些数据仅与之前的荟萃分析部分一致。
高钠摄入已被证明对心血管病的病理生理机制有很大的影响。
除了记录在案的对血压的影响(动脉粥样硬化的一个公认的危险因素)外, 高盐摄入对左心室质量、动脉僵硬度、肾功能、心输出量和交感神经传导的改变有不利影响。
常见的潜在机制包括过度炎症和氧化应激[6]。
动脉粥样硬化斑块的筛查与临床管理专家共识(2022版)

动脉粥样硬化斑块的筛查与临床管理专家共识一、《共识》产生的背景随着我国人口老龄化及城镇化进程的加速,动脉粥样硬化性心血管疾病(ASCVD)的发病率及死亡率逐年上升。
如能在疾病的早期识别并有效地控制危险因素,可进一步降低ASCVD 的发生率和死亡率。
尽管采用传统的心血管风险评分可以很好地估计人群水平的风险,但在预测个体风险时往往不够准确。
动脉粥样硬化斑块是个体动脉粥样硬化的直接标志物,反映了特定个体所有危险因素综合起来的终生影响,识别斑块的存在及特征对疾病的临床早期诊断及治疗尤为重要。
近年来,影像学的进展使得我们可以更直观准确地识别斑块的组分和形态,基于斑块筛查和管理的临床研究也取得了长足进展,为我们制定管理策略提供了参考依据。
二、动脉粥样硬化斑块形成的发病机制与危险因素动脉粥样硬化的发生发展涉及多种学说[2],脂质浸润学说是目前公认的学说。
该学说认为:低密度脂蛋白胆固醇(LDL‐C)及其他含有载脂蛋白B(Apo B)的脂蛋白胆固醇在动脉壁内的沉积,是导致动脉粥样硬化形成的始动环节。
沉积在动脉内皮下的LDL‐C,被巨噬细胞吞噬形成泡沫细胞,泡沫细胞累积形成脂质条纹并逐渐演变成动脉粥样硬化斑块。
同时过多的LDL‐C沉积会诱发产生更多的凋亡细胞[3],巨噬细胞虽然可以吞噬并清除凋亡细胞,但在超过巨噬细胞的吞噬能力后,斑块会不断增长并伴随着脂质的堆积形成薄纤维帽斑块,如发生斑块破裂或侵蚀,则会导致严重的心脑血管缺血性疾病。
此外,炎症反应在动脉粥样硬化斑块形成和失稳定过程中也扮演重要的角色。
动脉粥样硬化是多种复杂因素作用于不同环节所导致的慢性进展性病理过程,其主要特征是LDL‐C 在受损动脉壁中积累而形成斑块[5]。
动脉粥样硬化斑块形成和进展的危险因素分为不可改变的和可改变的危险因素。
➤不可变因素:年龄、遗传、种族与性别等➤可变因素:血脂异常、高血压、糖尿病、吸烟、肥胖与超重、心理因素、缺乏运动与炎症等LDL‐C 在动脉粥样硬化的发生和发展过程中发挥关键作用,是最强的可改变危险因素。
营养学练习(单选多选等)

一、填空1.维生素D的缺乏症有()、骨质软化症、()、和()。
2.必需脂肪酸最好的食物来源是()和()。
3.除8种必需氨基酸外,还有()是婴幼儿不可缺少的氨基酸。
4.水溶性维生素包括()和()。
5.()和()含钙量丰富且吸收率高,是钙的良好来源。
6.人体热能需要的测定方法有()和()7.烟酸缺乏引起的“三D”症状包括()、()和()。
8.与胎儿“神经管畸形”形成密切相关的维生素是()9.硫胺素缺乏引起的脚气病主要有()、()、急性暴发性脚气病三种类型。
10.人体的热能消耗包括()、()和()三方面。
11.缺铁性贫血期主要表现为()和()下降。
12.铁损耗的三个阶段包括()、红细胞生成缺铁期和()。
13.蛋白质和能量同时严重缺乏的后果可产生()症。
14.亚油酸主要存在于()中。
15.目前认为营养学上最具价值的脂肪酸有()和()两类不饱和脂肪酸。
16.营养学上,主要从()、()和被人体利用程度三方面来全面评价食品蛋白质的营养价值。
二、单选题1.血胆固醇升高时,血中()浓度增加。
A.HDL B.LDL C.糖蛋白D.球蛋白2.膳食蛋白质中非必需氨基酸()具有节约蛋氨酸的作用。
A.半胱氨酸B.酪氨酸C.精氨酸D.丝氨酸3.婴幼儿和青少年的蛋白质代谢状况应维持()A.氮平衡B.负氮平衡C.排出足够的尿素氮D.正氮平衡4.维持人体基本生命活动的能量消耗是()A.体力活动耗能B.基础代谢C.非体力活动耗能D.食物热效应耗能。
5.能促进钙吸收的措施是()A.经常在户外晒太阳B.经常做理疗(热敷)C.多吃谷类食物D.多吃蔬菜、水果6.具有激素性质的维生素是()A.维生素B1 B.维生素B2 C.维生素D D.维生素PP7.维生素B2缺乏体征之一是()A.脂溢性皮炎B.周围神经炎C.“三D”症状D.牙龈疼痛出血8.能被人体消化吸收的碳水化合物是()A.棉籽糖B.果胶C.纤维素D.淀粉9.膳食蛋白质中非必需氨基酸()具有节约苯丙氨酸的作用。
我国动脉粥样硬化基础研究近三年进展

1、炎症反应对动脉粥样硬化发生发展的影响
炎症反应在动脉粥样硬化的发生发展过程中起着关键作用。细胞因子、炎性 介质和氧化应激等炎症因素可刺激血管内皮细胞,导致内皮细胞功能失调,促进 血管平滑肌细胞增殖和迁移,从而形成动脉粥样硬化斑块。此外,炎症反应还可 促进斑块的不稳定性和破裂,导致急性心血管事件的发生。
内容摘要
近年来,随着基础研究的深入,对AS的发病机制和防治策略有了新的认识。 研究发现,AS是一种慢性炎症性疾病,炎症反应在AS的发生和发展中发挥重要作 用。巨噬细胞和其他炎症细胞在动脉粥样斑块中的浸润和活化导致炎症反应和血 栓形成,从而加速AS的发展。因此,针对炎症反应的靶向治疗成为防治AS的新策 略。
研究方法
然而,目前研究方法仍存在一定的局限性。首先,动物模型与人类疾病存在 差异,可能影响研究的可靠性。其次,当前研究多单个因素或信号通路,而动脉 粥样硬化发病机制的复杂性要求研究应更全面、系统。
主要成果与不足
主要成果与不足
近三年,我国动脉粥样硬化基础研究取得了显著成果。研究人员在基因组学、 蛋白质组学、代谢组学等多个层面揭示了动脉粥样硬化发生发展的内在机制。此 外,针对动脉粥样硬化的干预手段和治疗策略也得到了进一步明确。
2、动脉粥样硬化对炎症反应的 促进作用
2、动脉粥样硬化对炎症反应的促进作用
动脉粥样硬化病变本身可促进炎症反应的进展。斑块内巨噬细胞和其他免疫 细胞可分泌炎性介质,如肿瘤坏死因子-α(TNF-α)、白细胞介素-1(IL-1) 等,进一步刺激炎症反应。此外,动脉粥样硬化斑块中的氧化应激也可促进炎症 反应,导致病情恶化。
我国动脉粥样硬化基础研究 近三年进展
01 引言
03 研究方法 05 结论
目录
02 研究现状 04 主要成果与不足 06 参考内容
ASCVD患者的血脂管理策略答案-2024年华医网继续教育临床内科学心血管病学

ASCVD患者的血脂管理策略答案2024年华医网继续教育临床内科学心血管病学目录一、家族性高胆固醇血症(一) (1)二、家族性高胆固醇血症(二) (3)三、家族性高胆固醇血症(三) (5)四、家族性高胆固醇血症(四) (7)五、降脂药物的前世今生 (9)六、现有主要降脂药物的分类和临床证据 (11)七、新型靶向降脂药PSCK9抑制剂 (12)八、冠心病患者的血脂管理 (14)九、脂蛋白(a)——被忽视的靶点(一) (16)十、脂蛋白(a)——被忽视的靶点(二) (18)十一、 ASCVD患者血脂的管理 (20)十二、“脂”上谈“兵”多“刃”齐发 (22)十三、高甘油三酯血症(一) (24)十四、高甘油三酯血症(二) (26)十五、 ASCVD血脂异常患者:尽早联合达标 (28)一、家族性高胆固醇血症(一)1.以下哪一项不是FH的临床特征()A.血清LDL-C水平明显升高B.早发ASCVDC.黄色瘤D.脂性角膜弓E.低血钾参考答案:E2.FH的诊断标准之一是成人未接受调脂药物治疗的情况下,血清LDL-C水平应达到多少()A.≥3.8mmol/LB.≥4.7mmol/LC.≥5.5mmol/LD.≥6.0mmol/LE.≥7.0mmol/L参考答案:B3.以下哪项不属于家族性高胆固醇血症有效的治疗方法()A.饮食控制B.LDL分离术C.肝脏移植D.自体干细胞移植术E.调脂药物参考答案:D4.以下哪项不属于家族性高胆固醇血症的常见临床表现()A.HDL-C水平极度降低B.LDL-C水平极度增高C.角膜弓D.早发冠心病E.皮肤肌腱黄色瘤参考答案:A5.家族性高胆固醇血症(FH)是一种什么类型的遗传病()A.常染色体隐性遗传B.X连锁遗传C.Y连锁遗传D.常染色体显性遗传E.线粒体遗传参考答案:D二、家族性高胆固醇血症(二)1.下列哪一项疾病不宜首选HMG-CoA还原酶抑制药治疗()A.原发性高胆固醇症B.纯合子家族性高胆固醇血症C.杂合子家族性高胆固醇血症D.Ⅲ型高脂蛋白血症E.肾性和糖尿病性高脂血症参考答案:D2.FH患者在未接受治疗的情况下,杂合子(HeFH)和纯合子(HoFH)的血清LDL-C水平分别约为正常人的多少倍()A.1倍和2倍B.2倍和3倍C.2倍和4倍D.3倍和5倍E.4倍和8倍参考答案:C3.FH的治疗目标中,成人FH患者伴临床ASCVD的LDL-C目标值应低于多少()A.1.4mmol/LB.1.8mmol/LC.2.6mmol/LD.3.5mmol/LE.4.7mmol/L参考答案:A4.FH的筛查标准中,哪一项不是必需的()A.早发ASCVD(男性<55岁或女性<65岁即发生ASCVD)B.成人血清LDL-C≥3.8mmol/L(146.7mg/dl)C.儿童血清LDL-C≥2.9mmol/L(112.7mg/dl)D.一级亲属中有早发ASCVD - 正确答案E.存在皮肤/腱黄素瘤或脂性角膜弓(<45岁)参考答案:D5.FH患者在使用最大耐受剂量的他汀类药物和依折麦布后,如果LDL-C水平仍未达标,下一步应采取什么措施()A.停止所有药物治疗B.开始生活方式的改变C.加用PCSK9抑制剂D.增加他汀类药物的剂量E.使用胆汁酸螯合剂参考答案:C三、家族性高胆固醇血症(三)1.他汀类药物治疗后,LDL受体表达增加的同时,循环中的什么物质水平也会增加,从而影响LDL-C的清除()A.胆固醇B.甘油三酯C.HDLD.PCSK9E.载脂蛋白B参考答案:D2.在ORION-10临床试验中,英克司兰治疗的ASCVD患者在第90-540天期间的LDL-C较基线的变化是多少()A.减少10%B.减少30%C.减少54%D.减少70%E.减少80%参考答案:C3.以下哪一项是FH患者LDL-C水平升高导致的后果()A.降低心血管疾病风险B.增加动脉粥样硬化斑块形成C.减少动脉粥样硬化性心血管疾病(ASCVD)事件D.降低LDL-C时间累积E.增加高密度脂蛋白(HDL)水平参考答案:B4.英克司兰的给药频率是怎样的()A.每日一次B.每周一次C.每月一次D.每季度一次E.每半年一次参考答案:E5.FH患者在治疗上面临的主要挑战是()A.无法使用他汀类药物B.他汀类药物无法单独满足降脂需求C.他汀类药物完全无效D.所有FH患者对降脂治疗有抗性E.FH患者不需要降脂治疗参考答案:B四、家族性高胆固醇血症(四)1.依洛尤单抗在治疗多长时间后可显著降低LDL-C水平()A.24小时B.1周C.1个月D.3个月E.6个月参考答案:A2.对于糖尿病合并ASCVD的患者,《中国血脂管理指南(2023)》推荐的LDL-C目标值是多少()A.<1.8mmol/LB.<1.4mmol/LC.<2.6mmol/LD.<3.5mmol/LE.<4.9mmol/L参考答案:B3.《中国血脂管理指南(2023)》中,危险分层更加细化,特别提出了哪一类患者()A.一级预防患者B.二级预防患者C.超高危患者D.极低危患者E.中危患者参考答案:C4.在FOURIER-OLE研究中,接受依洛尤单抗治疗的患者,平均LDL-C水平在260周时达到多少()A.1.0mmol/LB.1.5mmol/LC.2.0mmol/LD.2.5mmol/LE.3.0mmol/L参考答案:A5.对于超高危患者,当预计他汀类联合胆固醇吸收抑制剂不能达标时,应考虑什么治疗方案()A.直接采用更强的他汀类药物B.停止所有降脂药物C.采用他汀类联合PCSK9抑制剂D.仅采用生活方式干预E.采用他汀类联合烟酸参考答案:C五、降脂药物的前世今生1.HMG-CoA还原酶是胆固醇合成过程中的()A.首步酶B.限速酶C.最终酶D.中间酶E.辅助酶参考答案:B2.以下哪种药物是3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制药()A.阿司匹林B.氯吡格雷C.瑞舒伐他汀D.依折麦布E.阿托伐他汀参考答案:C3.以下哪项不是临床血脂检测的项目()A.总胆固醇B.甘油三酯C.LDL-CD.血红蛋白E.高密度脂蛋白胆固醇参考答案:D4.以下哪种药物可以升高HDL-C()A.阿托伐他汀B.瑞舒伐他汀C.普伐他汀D.依折麦布E.烟酸参考答案:E5.被认为是ASCVD致病性危险因素的是()A.总胆固醇B.甘油三酯C.LDL-CD.高密度脂蛋白胆固醇E.非HDL-C参考答案:C六、现有主要降脂药物的分类和临床证据1.他汀类药物治疗可使心血管死亡风险降低多少百分比()A.14%B.31%C.6%D.9%E.12%参考答案:B2.在CURVES和VOYAGER等研究中,关于他汀类药物剂量增加时的降脂效果,以下哪一项描述正确()A.每增加一倍剂量,降脂效果增加18%B.每增加一倍剂量,降脂效果增加约6%C.增加剂量不会带来任何额外的降脂效果D.每增加一倍剂量,降脂效果增加10%E.增加剂量会降低降脂效果参考答案:B3.以下哪种药物属于HMG-CoA还原酶抑制剂()A.阿托伐他汀B.依折麦布C.伊洛尤单抗D.阿利西尤单抗参考答案:A4.依折麦布是一种什么类型的药物()A.HMG-CoA还原酶抑制剂B.PCSK9抑制剂C.胆固醇吸收抑制剂D.胆汁酸螯合剂E.烟酸类似物参考答案:C5.PCSK9抑制剂通过何种方式降低LDL-C水平()A.抑制胆固醇的肠道吸收B.抑制肝脏中胆固醇的合成C.上调肝脏中的LDL受体D.促进LDL颗粒的分解E.降低甘油三酯水平参考答案:C七、新型靶向降脂药PSCK9抑制剂1.以下哪种细胞在动脉粥样硬化斑块的形成中与PCSK9相互作用()A.红细胞B.白细胞C.血小板D.肝细胞E.肌肉细胞参考答案:B2.PCSK9如何影响LDL受体的数量()A.增加LDL受体的数量B.减少LDL受体的数量C.不影响LDL受体的数量D.只在特定条件下增加LDL受体的数量E.通过间接途径增加LDL受体的数量参考答案:B3.PCSK9抑制剂对动脉粥样硬化斑块有什么影响()A.增加斑块体积B.减少斑块体积C.无影响D.增加斑块硬度E.减少斑块硬度参考答案:B4.PCSK9抑制剂的治疗如何影响中性粒细胞和嗜酸性粒细胞()A.增加活性和趋化性B.减少活性和趋化性C.不影响活性和趋化性D.增加活性,减少趋化性E.减少活性,增加趋化性参考答案:B5.PCSK9在体内的其他作用包括什么()A.促进胰岛β细胞的葡萄糖稳态B.增加血红蛋白的合成C.减少血小板的凝集D.增加白细胞的寿命E.促进神经元的再生参考答案:A八、冠心病患者的血脂管理1.英克司兰在冠心病患者血脂管理中的优势不包括()A.长期降低LDL-C水平B.减少心血管事件C.方便的给药方式D.提高HDL-C水平E.良好的安全性参考答案:D2.英克司兰的给药方案是怎样的()A.每日口服一次B.每周注射一次C.每月注射一次D.每季度注射一次E.首针后三个月注射加强针,此后一年两次参考答案:E3.LDL-C水平每降低1mmol/L,心血管事件风险降低的百分比大约是()A.10%B.20%C.30%D.40%E.50%参考答案:E4.大量研究证实,降低哪种脂蛋白是心血管事件防治的主要靶点()A.高密度脂蛋白(HDL)B.极低密度脂蛋白(VLDL)C.低密度脂蛋白(LDL)D.乳糜微粒(CM)E.脂蛋白(a)(Lp(a))参考答案:C5.英克司兰能够降低LDL-C水平的幅度大约是多少()A.10%B.20%C.30%D.40%E.54%参考答案:E九、脂蛋白(a)——被忽视的靶点(一)1.Lp(a)水平升高患者的一级亲属应进行什么()A.定期眼科检查B.定期听力测试C.级联筛查D.定期心理评估E.定期骨密度检查参考答案:C2.在10年ASCVD风险为7.5%-19.9%的40-75岁成年人中,Lp(a)≥125nmol/L或≥50mg/dL可促使什么治疗()A.高强度降压治疗B.中等或高强度他汀治疗C.抗生素治疗D.低强度降脂治疗E.非药物治疗参考答案:B3.Lp(a)≥125nmol/L或≥50mg/dL的水平在什么人群中被视为风险增强因素()A.儿童B.健康成年人C.40-75岁成年中危个体D.老年人E.妊娠女性参考答案:C4.Lp(a)水平升高在临床实践中可用作什么()A.肝功能指标B.肾功能指标C.心血管疾病风险增强因素D.糖尿病风险预测E.肿瘤标志物参考答案:C5.Lp(a)水平升高的患者应接受什么类型的管理()A.无需特殊管理B.生活方式改变和降脂药物治疗C.高强度体育锻炼D.单纯药物治疗E.单纯生活方式改变参考答案:B十、脂蛋白(a)——被忽视的靶点(二)1.Lp(a)升高还可见于下列哪种情况()A.长期素食B.长期禁食C.急性时相反应D.长期静坐E.长期睡眠不足参考答案:C2.Lp(a)的浓度在新生儿时期大约是成人水平的多少()A.1/2B.1/3C.1/4D.1/5E.1/10参考答案:E3.Lp(a)升高但LDL-C↓者,发生冠心病的概率大约是多少()A.5%B.10%C.15%D.20%E.25%参考答案:B4.Lp(a)在妊娠期会发生什么变化()A.保持稳定B.显著升高C.显著降低D.生理性波动E.不可预测变化参考答案:D5.下列哪种方法被推荐用于临床实验室测定血清Lp(a)()A.ELISAB.免疫浊度法C.PCRD.色谱法E.光谱法参考答案:B十一、ASCVD患者血脂的管理1.欲判断患者是否在1周前左右发生急性心肌梗死,最有价值的检查是()A.超声心动图B.冠状动脉造影C.肌钙蛋白测定D.心肌核素显像E.心脏磁共振成像参考答案:C2.最能反映存在急性心肌缺血的辅助检查结果是()A.冠状动脉造影显示血管狭窄>70%B.心电图出现ST-T动态改变C.超声心动图出现弥漫性室壁运动减弱D.监测血压出现收缩压波动超过40mmHgE.血清心肌酶谱显著升高参考答案:B3.男性,69岁。
茶多酚的药理作用研究进展

茶多酚的药理作用研究进展摘要:综述了茶多酚作为茶叶中具有重要生理活性的多种有效成分混合物,具有抗动脉粥样硬化、抗氧化等药理作用,对动脉粥样硬化、心血管等疾病有一定的预防和治疗作用。
关键词:茶多酚;化学结构;药理作用在我国,茶叶是仅次于水而被人们广泛消费的饮料,作为一种传统饮料在我国已有上千年的历史,茶叶系山茶科植物茶树(CamelIiasinenis o. Ktze.)的干燥嫩叶或叶芽,作为软饮料,很有营养、保健和药用价值[1]。
东汉的《神农本草》、唐代陈藏器的《本草拾遗》、明代顾元庆《茶谱》等史书,均详细记载了茶叶的药用功效。
近年,随着对茶叶有效成分的深入研究,其主要成分茶多酚的营养、保健和药理作用倍受关注,并已应用于临床实际。
现将茶多酚药理作用的研究进展介绍如下。
1 茶多酚的组成和化学结构茶多酚(tea polyphenol,TP)在茶叶(特别是绿茶) 中含量较高,占茶叶干重的30%左右,其中儿茶素类化合物为TP的主要成分,约占TP总量的65%~80%,主要含有4种单体:表没食子儿茶素没食子酸酯( Epigallocatechin gallate, EGCG)、表儿茶素没食子酸酯( Epicabechin gallate, ECG)、表儿茶素( Epicatechin,EC)及表没食子儿茶素( Epigallocatechin, EGC),化学结构式如图1。
其中, EGCG含量最高, 约占儿茶素的50%左右[3]。
2 药理作用2.1 抗氧化作用茶多酚是一类含有多酚羟基的化学物质,能清除人体内过剩的活性自由基,具有极强的抗氧化作用。
茶多酚一方面可通过抑制氧化酶,减少自由基的生成,以提高其抗氧化作用;另一方面通过灭活自由基,保护抗氧化酶,还能提高体内抗氧化酶的活性进而增强抗氧化作用[2]。
其抗氧化特性通过下述几种途径体现。
首先, TP的酚羟基能作为供氢体,提供质子H+, 将单线态氧1O2 还原成活性较低的三线态氧 3O2,减少氧自由基产生的可能性;并能夺取过氧化过程中产生的脂质过氧化自由基,生成活性较低的多酚自由基,打断自由基氧化链反应,有效清除体内自由基。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Original ArticleThe effects of green tea ingestion over four weeks on atherosclerotic markersHeungsup Sung1,Won-Ki Min1,Woochang Lee1,Sail Chun1,Hyosoon Park2,Yong-Wha Lee1,Seongsoo Jang1and Do-Hoon Lee3AbstractAddresses1Department of Laboratory Medicine,Asan Medical Center and University of College of Medicine,388-1Pungnap-dong,Songpa-Gu,Seoul138-736,South Korea 2Department of Laboratory Medicine, Kangbuk Samsung Hospital and Sungkyunkwan University School of Medicine,Seoul,Korea3Department of Diagnostic Laboratory, National Cancer Center,Goyang, Gyeonggi,KoreaCorrespondenceProfessor Dr Won-Ki MinE-mail:wkmin@amc.seoul.kr Background The objective of this study was to evaluate the effects of green tea ingestion over four weeks on atherosclerotic biological markers.Methods After a one-week baseline period,12healthy male volunteers aged 28–42years drank600mL of green tea daily for four weeks.Lipid profile,oxidized low-density lipoprotein(ox-LDL),total antioxidant capacity(TAC),C-reactive protein (CRP)and soluble cell adhesion molecules were measured at baseline and after two and four weeks ingestion of green tea.Results There was no significant change in the concentrations of lipid profile, TAC,CRP,soluble intercellular adhesion molecule-1(sICAM-1),or soluble E-selectin after ingestion of green tea.The levels of ox-LDL and soluble vascular cell adhesion molecule-1(sVCAM-1)were significantly decreased after four weeks of green tea ingestion(Wilcoxon signed rank test,P¼0.006).Conclusions The results of this study suggest an in vivo anti-oxidative effect for green tea and an influence of green tea on atherosclerotic biological markers.The effect of green tea seen on ox-LDL and sVCAM-1provides a potential mechanism for the cardiovascular benefits of regular ingestion of green tea.Ann Clin Biochem2005;42:292–297IntroductionTea is the most widely consumed drink in the world other than water.1Tea is made of Camellia sinensis leaves and classi¢ed as green tea,black tea or oolong tea according to the degree of fermentation.The tea leaf contains polyphenolic£avonoids(over30%of the dry weight),most of which in green tea are£avanols,com-monly known as catechins.2A few epidemiological studies have reported that the incidence of coronary heart disease and cancer de-creased with intake of green tea.3,4Tea or£avonoids de-rived from tea have in vitro antioxidant capacity5--7and green tea has been shown to suppress the oxidation of low-density lipoprotein(LDL)in vitro.5Previous studies have demonstrated that oxidation of human LDL is one of the risk factors in the development of atherosclero-sis8and that dietary antioxidants lower the incidence of coronary heart diseases.9We have previously reported that the total anti-oxidant capacity(TAC)of plasma was signi¢cantly increased after ingestion of green tea in amounts of300and450mL,and the increment was dose related.10There are some other reports that the TAC increased after tea-drinking.7,11,12However,the rela-tionship between long-term ingestion of green tea and in vivo oxidation of LDL has seldom been investigated.13V ascular cell adhesion molecule-1(VCAM-1)and in-tercellular adhesion molecule-1(ICAM-1)mediate the adherence of leucocytes to the vascular endothelium and are therefore crucial for the initiation and progres-sion of atherosclerosis.14Indeed,plasma levels of their soluble forms predict the cardiovascular risk in healthy individuals15,16and in patients with coronary artery disease.17In this study,we measured the concentrations of atherosclerotic biological markers before and two and292r2005The Association of Clinical Biochemistsfour weeks after ingestion of green tea to ascertain the in vivo e¡ect of green tea ingestion.Materials and methodsHuman subjectsThe study was conducted in12healthy male volun-teers aged28--42years.Potential volunteers were ex-cluded after initial screening if they reported the use of any medication or dietary supplements.Further ex-clusion criteria consisted of a history of major illness, including heart disease,diabetes mellitus,liver disease and renal disease,a body mass index(BMI)430kg/m2, alcohol intake averaging440g/day,or regular tea or co¡ee intake averaging41cup/day.Before the study, subjects were instructed to avoid drinking tea or other antioxidant-containing beverages for one week;other-wise they kept to their usual diet and lifestyle.This study had the approval of the Ethical Committee of the Asan Medical Center.Written informed consent was obtained from every volunteer.Experimental designEach subject took150mL of green tea four times a day(09:00,11:00,13:00and15:00)for four weeks. They were asked to abstain from wine,other types of tea and special dietary additives,but to otherwise continue their usual daily diet throughout the trial pliance was checked by one of our inves-tigators(HS)from Monday to pliance on Sundays was con¢rmed by direct questioning. Blood specimens were taken just before the start of the study(baseline)and two and four weeks into the study. All the samples were taken after a12-h fast to rule out the acute e¡ect of green tea intake.Heparinized blood for antioxidant capacity and soluble cellular adhesion molecule(sCAM)measurement,EDTA plas-ma for oxidized LDL(ox-LDL)measurement and serum for lipid pro¢le and high-sensitivity C-reactive protein (hs-CRP)measurement were collected in a sodium heparin tube,a K2EDTA tube and an SST tube, respectively(all from Becton DickinsonV acutainer Sys-tems,NJ,USA).Preparation of teaTea infusions were prepared with commercially avail-able tea bags(JinHyang,Amore Paci¢c Corporation, Seoul,Korea).One batch equalled25tea bags.In vitro, a tea bag was dipped into150mL boiled tap water(tem-perature60--701C)and was allowed to stand for2min. The antioxidant concentration of30tea prepara-tions was measured.The mean(7standard deviation) total antioxidant concentration of1.3g of green tea in150mL water was8.8970.41mmol/L.When the antioxidant capacity of randomly selected tea bags from each batch were within mean72SD,the tea bags of that batch were used.Every cup of tea was prepared by one of our investigators(HS)from Monday to Satur-day.A tea bag containing1.3g of tea leaves was dipped into150mL of boiled tap water(temperature60--701C). On Sunday,the participants prepared the tea them-selves.We asked them to pour150mL of boiled tap water into a scaled paper cup,wait for3min and dip one tea bag into the water.The mixture was allowed to stand for2min.Tea infusions were consumed hot and with no milk or sugar added.CRP in serumWe measured hs-CRP using an immunoturbidimetric method(CRPLX,Roche Diagnostics,Indianapolis,IN, USA)on a COBAS INTEGRA700analyser(Roche Diag-nostics).The lower detection limit of the hs-CRP was 0.064mg/L.Internal quality control procedures are carried out3--4times daily.The target CV value is o2%and was maintained as such.Our laboratory has been participating in the College of American Patholo-gists(CAP)survey and inspection.Oxidized LDL in plasmaPlasma ox-LDL concentrations were measured by sandwich ELISA(intra-assay CV was3.4%and inter-assay CV was6.7%;Mercodia AB,Uppsala,Sweden), utilizing the same speci¢c murine monoclonal anti-body,mAB-4E6,as the assay described by Holvoet et al.18,19In order to avoid systematic di¡erences in the current study,two internal controls were repeatedly included on all plates.TAC in plasmaThe Total Antioxidant Status kit(Randox Laboratories Ltd,Crumlin,UK)was applied to a Cobas Mira chemis-try analyser(Roche Diagnostics).The assay principle is as follows:2,20-azino-di-2-ethyl-benzthiazoline sul-phonate(ABTS)is incubated with a peroxidase(met-myoglobin)and H2O2to produce the radical cation ABTSþ.This has a relatively stable blue--green colour which is measured at600nm.Antioxidants in the added sample cause suppression of this colour produc-tion to a degree proportional to their concentration. The assay was calibrated against an a-tocopherol ana-logue(Trolox)and the results were expressed as mmol/ L of Trolox activity.To measure the accuracy and reproducibility of the kit,the Randox Total Antioxidant Control(Randox La-boratories Ltd,UK)was used;the intra-assay CV was 1.1%and inter-assay CV2.3%.Ann Clin Biochem2005;42:292–297 Effects of green tea ingestion on atherosclerotic markers293Soluble cellular adhesion molecules in plasmaThe concentrations of soluble VCAM-1(sVCAM-1), soluble ICAM-1(sICAM-1)and soluble E-selectin (sE-selectin)were measured by human sVCAM-1immu-noassay,human sICAM-1immunoassay and human sE-selectin immunoassay(R&D Systems Inc.,Minnea-polis,MN,USA),respectively.These assays employ the quantitative sandwich enzyme immunoassay techni-que using monoclonal antibodies speci¢c for each sCAM.StatisticsAll the statistical analyses were done with SPSS11.5 software(SPSS Inc.,Chicago,IL,USA).We compared the parameters after two and four weeks of green tea ingestion with the baseline parameters.As the data points were not normally distributed and the sample size was relatively small(n o20),we employed non-parametric statistics.For statistical analysis,hs-CRP concentrations below the detection limit were assigned a value of0.064mg/L.Results are expressed as median (interquartile range);signi¢cance was set at P o0.05. The di¡erences in biological markers according to duration of green tea ingestion were analysed statisti-cally using the Wilcoxon signed rank test. ResultsThe concentrations of ox-LDL after two weeks of green tea consumption decreased from69.5U/L(55.4--96.1)to 64.5U/L(49.9--73.4;P¼0.388)and there was a statisti-cally signi¢cant decrease after four weeks ingestion (54.8U/L[40.9--60.6]P¼0.006;Table1,Figure1a). The concentrations of sVCAM-1showed a similar pattern.There was a non-signi¢cant decrease after green tea consumption from323.8ng/mL(269.4--447.6)at baseline to300.5ng/mL(248.5--364.5)after two weeks(P¼0.774),and a signi¢cant decrease afterTable1Changes of atherosclerotic markers according to the duration of green tea intake*Baseline After two weeks After four weeks Total cholesterol(mmol/L) 5.04(3.90–5.77) 5.22(3.98–5.64) 4.84(4.16–5.48)P=0.774P=0.388 Triglyceride(mmol/L) 1.75(1.03–2.44) 1.55(0.88–2.11) 1.69(0.95–2.62)P=0.388P=1.000High-density lipoprotein cholesterol(mmol/L) 1.27(1.03–1.37) 1.19(1.14–1.42) 1.34(1.14–1.47)P=0.774P=0.146Low-density lipoprotein cholesterol(mmol/L) 2.87(2.17–3.49) 3.28(2.22–3.70) 2.84(2.43–3.21)P=0.774P=0.388 Oxidized low-density lipoprotein(U/L)69.5(55.4–96.1)64.5(49.9–73.4)54.8(40.9–60.6)wP=0.388P=0.006Total antioxidant capacity(mmol/L) 1.03(0.94–1.12) 1.04(0.98–1.10) 1.05(0.94–1.11)P=1.000P=1.000C-reactive protein(mg/L)0.33(0.06–0.82)0.06(0.06–0.07)0.06(0.06–0.06)P=0.453P=0.687Soluble vascular cell adhesion molecule-1(ng/mL)323.8(269.4–447.6)300.5(248.5–364.5)239.5(173.5–317.0)wP=0.774P=0.006Soluble intercellular adhesion molecule-1(ng/mL)217.2(177.7–257.5)232.0(171.2–267.2)209.2(181.0–252.3)P=0.388P=1.000Soluble E-selectin(ng/mL)43.4(29.8–53.0)45.6(33.2–58.1)46.3(37.1–53.2)P=0.146P=0.388*Data are represented by median(interquartile range)and P value compared with those at baseline by Wilcoxon signed rank test.Statistically significant differences compared with those at baseline(Wilcoxon signed rank test,w P o0.01).Ann Clin Biochem2005;42:292–297294Sung et al.four weeks (239.5ng/mL [173.5--317.0];P ¼0.006;Ta-ble 1,Figure 1b).The concentrations of sICAM-1and sE-selectin showed no signi¢cant change after two and four weeks of green tea consumption compared with those at baseline.The levels of TAC and CRP did not show signi¢cant change after two or four weeks of green tea consump-tion compared with those at baseline.DiscussionOur study shows a signi¢cant decrease in ox-LDL con-centration after four weeks daily green tea consump-tion of 600mL.While this is the ¢rst study of the e¡ects of subacute tea consumption using circulating ox-LDL as the marker for lipid oxidation,there have been several reports utilizing other markers.6,13,20,21Ishikawa et al .20reported that the lag time before LDL oxidation was signi¢cantly prolonged from 54to 62min in 14healthy volunteers after consuming 750mL of black tea per day for four weeks.Although there were di¡erences between our study and that of Ishikawa et al .in the tea used (green versus black tea),the amount of daily consumption and the measuring method for LDL oxidation,both studies demonstrated that four weeks of tea consumption had protective ef-fects on LDL oxidation in vivo .Several studies have shown that ingestion of tea can-not inhibit LDL oxidation ex vivo .6,13,21McAnlis et al .6re-ported a four-week crossover study in which co¡ee was used as a control against black tea,showing no signi¢-cant di¡erence in the TAC or susceptibility of LDL to oxidation between the tea and co¡ee groups.The tea group had a daily dose of 1500mL of black tea (equiva-lent to 126.8713.5mg £avonoids).van het Hof et al .13reported that daily consumption of 900mL (six cups)of green or black tea did not a¡ect serum lipid concen-trations,resistance of LDL to oxidation or markers of oxidative damage to lipids in vivo ,although consump-tion of green tea slightly increased the TAC of plasma.In addition,Princen et al .21showed that daily consump-tion of 900mL green or black tea for four weeks had no e¡ect on resistance of LDL to oxidation ex vivo .When Hodgson et al .22examined the acute e¡ects of black tea and green tea on lipoprotein oxidation ex vivo without prior isolation of lipoproteins from serum,they found that there was a greater lag time for black tea than water control and a similar trend for green tea.They suggested that the lack of e¡ects of tea on LDL oxi-dation ex vivo in previous controlled interventions 6,13,21might be related to the method used to assess LDL oxidizability .Isolated LDL from serum was used for the LDL oxidation assay in these studies.As the oxidation of lipoprotein occurs in the presence of the aqueous phase of serum,LDL should not be isolated from serum for measurement.van het Hof et al .23observed the dis-tribution of catechins in the body after drinking eight cups of green tea a day for three days.They reported that 60%were in a protein-rich fraction,23%in high-density lipoprotein (HDL)and less than 10%in LDL,and that the concentration of catechins in LDL was not su⁄cient to enhance the resistance of LDL to oxida-tion ex vivo .These ¢ndings suggest that measurement of lipid oxidation using LDL isolated from serum may not represent the in vivo e¡ects of green tea.We used plasma concentration of ox-LDL as a marker for in vivo oxidation.Ox-LDL is known to be a clinically useful marker of oxidative stress 24,25and is reported to be a biochemical risk marker for coronary heart dis-ease.18,19,26,27Ox-LDL was measured by a competitive ELISA method using monoclonal antibody mAb-4E6,although we recognize that the routine measurement of circulating ox-LDL in clinical laboratory has limi-tations,for example lack of standardization and little clinical data.18,19,26,27No previous study has examined the e¡ects of green tea on CAMs.In our study ,the concentration of sVCAM-1decreased signi¢cantly after four weeks of green tea ingestion,but there was no change inO x i d i z e d L D L (U /L )20406080100120BaselineAfter two weeks After four weekss V C A M -1 (n g /m L )100200300400500600700800(A)(B)Figure 1Changes of individual oxidized LDL (A)and soluble vascular cell adhesion molecules (B)according to the duration of green tea intake.Ann Clin Biochem 2005;42:292–297Effects of green tea ingestion on atherosclerotic markers295sICAM-1or sE-selectin inacini et al.28reported that the introduction of ox-LDL into hu-man umbilical vein endothelial cells showed increased induction of VCAM-1and ICAM-1compared with the introduction of ox-LDL,which had been pretreated with vitamin E and probucol before oxidation.The de-crease in sVCAM-1observed in our study could be re-lated to the antioxidant capacity of green tea.Peter et al.29suggest that serum concentration of sVCAM-1 had higher correlation with the degree of atherosclero-sis than other CAMs,and may be of help in the risk as-sessment for development of atherosclerosis.15,16TAC showed no signi¢cant change after two and four weeks of green tea consumption compared with basal concentration.Benzie et al.11reported that there was 4%increase in ferric/antioxidant power40min after taking400mL of green tea,which returned to basal value after2h.Sera¢ni et al.7reported that plasma TAC reached a peak at50min after drinking300mL of green tea and showed subsequent decrease.In stu-dies of long-term tea consumption,increases in total antioxidant activity were small(3--10%)and generally not signi¢cant.6,13The results of this study demonstrate that the con-centrations of ox-LDL and sVCAM-1were signi¢cantly decreased after four weeks’ingestion of green tea,and these suggest the anti-oxidant e¡ect of green tea and its in£uence on early in£ammatory reactions.The e¡ect of green tea on ox-LDL and sVCAM-1provides a potential mechanism for cardiovascular bene¢ts of regular in-gestion of tea.AcknowledgementsThis work was supported by grant from the Asan Insti-tute for Life Sciences.References1Weisburger JH.Tea and health:the underlying mechanisms.Proc Soc Exp Biol Med1999;220:271–52Graham HN.Green tea composition,consumption,and poly-phenol chemistry.Prev Med1992;21:334–503Bushman JL.Green tea and cancer in humans:a review of the literature.Nutr Cancer1998;31:151–94Sasazuki S,Kodama H,Yoshimasu K,et al.Relation between green tea consumption and the severity of coronary athero-sclerosis among Japanese men and women.Ann Epidemiol2000;10:401–85Luo M,Kannar K,Wahlqvist ML,O’Brien RC.Inhibition of LDL oxidation by green tea ncet1997;349:360–16McAnlis GT,McEneny J,Pearce J,Young IS.Black tea consumption does not protect low density lipoprotein from oxidative modification.Eur J Clin Nutr1998;52:202–67Serafini M,Ghiselli A,Ferro-Luzzi A.In vivo antioxidant effect of green and black tea in man.Eur J Clin Nutr1996;50: 28–328Witztum JL,Steinberg D.Role of oxidized low density lipoprotein in atherogenesis.J Clin Invest1991;88:1785–929Kritchevsky SB,Shimakawa T,Tell GS,et al.Dietary antioxi-dants and carotid artery wall thickness.The ARIC Study.Atherosclerosis Risk in Communities Study.Circulation1995;92:2142–5010Sung H,Nah J,Chun S,Park H,Yang SE,Min WK.In vivo antioxidant effect of green tea.Eur J Clin Nutr2000;54:527–9 11Benzie IF,Szeto YT,Strain JJ,Tomlinson B.Consumption of green tea causes rapid increase in plasma antioxidant power in humans.Nutr Cancer1999;34:83–712Serafini M,Laranjinha JA,Almeida LM,Maiani G.Inhibition of human LDL lipid peroxidation by phenol-rich beverages and their impact on plasma total antioxidant capacity in humans.J Nutr Biochem2000;11:585–9013van het Hof KH,de Boer HS,Wiseman SA,Lien N,Westrate JA, Tijburg LB.Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans.Am J Clin Nutr1997;66:1125–3214Blankenberg S,Barbaux S,Tiret L.Adhesion molecules and atherosclerosis.Atherosclerosis2003;170:191–20315Ridker PM,Hennekens CH,Roitman-Johnson B,Stampfer MJ, Allen J.Plasma concentration of soluble intercellular adhesion molecule1and risks of future myocardial infarction in apparently healthy ncet1998;351:88–9216Ridker PM,Hennekens CH,Buring JE,Rifai N.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.N Engl J Med2000;342:836–4317Blankenberg S,Rupprecht HJ,Bickel C,et al.Circulating cell adhesion molecules and death in patients with coronary artery disease.Circulation2001;104:1336–4218Holvoet P,Van Cleemput J,Collen D,Vanhaecke J.Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease.Arterioscler Thromb Vasc Biol2000;20: 698–70219Holvoet P,Mertens A,Verhamme P,et al.Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease.Arterioscler Thromb Vasc Biol2001;21:844–820Ishikawa T,Suzukawa M,Ito T,et al.Effect of teaflavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification.Am J Clin Nutr1997;66:261–621Princen HM,van Duyvenvoorde W,Buytenhek R,et al.No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers.Arterioscler Thromb Vasc Biol1998;18:833–4122Hodgson JM,Puddey IB,Croft KD,et al.Acute effects of ingestion of black and green tea on lipoprotein oxidation.Am J Clin Nutr 2000;71:1103–723van het Hof KH,Wiseman SA,Yang CS,Tijburg LB.Plasma and lipoprotein levels of tea catechins following repeated tea consumption.Proc Soc Exp Biol Med1999;220:203–924Tsutsui T,Tsutamoto T,Wada A,et al.Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.J Am Coll Cardiol2002;39: 957–6225Tsutamoto T,Wada A,Matsumoto T,et al.Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy.J Am Coll Cardiol2001;37:2086–9226Toshima S,Hasegawa A,Kurabayashi M,et al.Circulating oxidized low density lipoprotein levels.A biochemical risk marker for coronary heart disease.Arterioscler Thromb Vasc Biol2000;20:2243–7Ann Clin Biochem2005;42:292–297 296Sung et al.27Suzuki T,Kohno H,Hasegawa A,et al.Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease.Clin Biochem2002;35: 347–5328Cominacini L,Garbin U,Pasini AF,et al.Antioxidants inhibit the expression of intercellular cell adhesion molecule-1and vascular cell adhesion molecule-1induced by oxidized LDL on humanumbilical vein endothelial cells.Free Radic Biol Med1997;22: 117–2729Peter K,Weirich U,Nordt TK,Ruef J,Bode C.Soluble vascular cell adhesion molecule-1(VCAM-1)as potential marker of atherosclerosis.Thromb Haemost1999;82:38–43Accepted for publication29April2005Ann Clin Biochem2005;42:292–297 Effects of green tea ingestion on atherosclerotic markers297。